News for hackers. Stuff that matters.
Re:How India's Patent Office Destroyed Gilead's Global Game ... by striking on Friday January 16, 2015 @09:24AM (#8899030)
FDA trials are only required to compete against a placebo. A drug is accepted if it is safe and more effective than a placebo in a double-blind clinical trial. That's it.

So they have no data to show with, unless they went above and beyond to get it. (Which should teach them a lesson about testing their drugs.)

Re:How India's Patent Office Destroyed Gilead's Global Game ... by refurb on Friday January 16, 2015 @10:53AM (#8899622)
You don't have to have head-to-head data to claim your drug is superior to existing therapies. Yes, head-to-head data is the best way to show it, but if you have two separate trials, each comparing to a placebo, you can draw conclusions about relative efficacy. It's not perfect, but in the case of Gilead, their drug blows away anything else currently on the market.